Form 4: Teladoc Health's Chief Medical Officer, Vidya Raman-Tangella, Reports Stock Transactions

Vidya Raman-Tangella, Chief Medical Officer of Teladoc Health, reports the acquisition and disposal of common stock and derivative securities, including performance stock units and restricted stock units, in recent transactions.

Summary

• Vidya Raman-Tangella, the Chief Medical Officer of Teladoc Health, filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2024, Raman-Tangella acquired 3,169 shares and 9,300 shares of common stock through the conversion of performance stock units and restricted stock units, respectively.
• Also on March 1, 2024, 9,509 performance stock units were acquired.
• On March 4, 2024, Raman-Tangella sold 4,599 shares of common stock at a price of $14.516 per share to cover tax withholding obligations.
• Following these transactions, Raman-Tangella directly owns 22,607 shares of common stock, 9,509 performance stock units, and 18,602 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are routine and related to compensation and tax obligations. There's no indication of unusual activity or concern.

Positives

• The acquisition of performance stock units indicates alignment with the company's performance metrics.

Negatives

• The sale of shares, although for tax obligations, could be perceived negatively by some investors.

Risks

• The document does not explicitly mention any risks, but the sale of shares, even for tax purposes, could be interpreted as a lack of confidence, although this is unlikely.

Future Outlook

The performance stock units vest over time, aligning the executive's interests with the company's long-term performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is important for investor confidence.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding insider activity.

Key Dates